Industry News
UAE Investments in AI and Genomics Drive Middle East Biopharma Expansion
A report by World Health Expo and Frost & Sullivan indicates that UAE national investments in genomics, artificial intelligence, and advanced manufacturing are transforming Middle Eastern biopharma. The regional precision medicine sector is forecast to expand by over 10 percent over the next five to seven years. Key initiatives include the Emirati Genome Program, Abu Dhabi's AED 42 billion HELM cluster, and the 2025 launch of Mubadala Bio.
